Optimism and recovery after acute coronary syndrome: a clinical cohort study

Psychosomatic Medicine
Amy RonaldsonAndrew Steptoe

Abstract

Optimism is associated with reduced cardiovascular mortality, but its impact on recovery after acute coronary syndrome (ACS) is poorly understood. We hypothesized that greater optimism would lead to more effective physical and emotional adaptation after ACS and would buffer the impact of persistent depressive symptoms on clinical outcomes. This prospective observational clinical study took place in an urban general hospital and involved 369 patients admitted with a documented ACS. Optimism was assessed with a standardized questionnaire. The main outcomes were physical health status, depressive symptoms, smoking, physical activity, and fruit and vegetable consumption measured 12 months after ACS, and composite major adverse cardiac events (cardiovascular death, readmission with reinfarction or unstable angina, and coronary artery bypass graft surgery) assessed over an average of 45.7 months. We found that optimism predicted better physical health status 12 months after ACS independently of baseline physical health, age, sex, ethnicity, social deprivation, and clinical risk factors (B = 0.65, 95% confidence interval [CI] = 0.10-1.20). Greater optimism also predicted reduced risk of depressive symptoms (odds ratio = 0.82, 95% CI =...Continue Reading

References

Apr 29, 1999·Archives of Internal Medicine·M F ScheierC S Carver
Apr 24, 2001·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Z M ShnekS Abbey
May 30, 2003·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·F P CappuccioA Steptoe
Feb 28, 2004·Journal of Psychosomatic Research·Jacqueline J M H StrikAdriaan Honig
Jun 10, 2004·JAMA : the Journal of the American Medical Association·Kim A EagleUNKNOWN GRACE Investigators
Jan 19, 2006·Annals of Internal Medicine·David A AlterUNKNOWN SESAMI Study Group
Jan 21, 2006·Journal of General Internal Medicine·Brett D ThombsRoy C Ziegelstein
Oct 3, 2006·Psychosomatic Medicine·Karina W DavidsonUNKNOWN National Heart, Lung, and Blood Institute Working Group
Sep 17, 2008·International Journal of Cardiology·Mimi R BhattacharyyaAndrew Steptoe
Mar 11, 2009·Brain, Behavior, and Immunity·Lena BrydonAndrew Steptoe
Nov 7, 2009·Stroke; a Journal of Cerebral Circulation·Hermann NabiMika Kivimäki
Feb 23, 2010·Clinical Psychology Review·Charles S CarverSuzanne C Segerstrom
Apr 1, 2011·Journal of Behavior Therapy and Experimental Psychiatry·Yvo M C MeevissenHugo J E M Alberts
Jun 3, 2011·European Heart Journal·Andrew SteptoeJuan Carlos Kaski
Jul 6, 2011·European Heart Journal·Julia K BoehmLaura D Kubzansky
Mar 7, 2012·Archives of General Psychiatry·Elizabeth A FreiheitColleen J Maxwell
Mar 30, 2012·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Chris DickensLinda McGowan
Feb 26, 2013·The American Journal of Cardiology·Julia K BoehmLaura D Kubzansky
Feb 26, 2014·Circulation·Judith H LichtmanUNKNOWN American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascu
Mar 22, 2014·Circulation. Heart Failure·Eric S KimLaura D Kubzansky

❮ Previous
Next ❯

Citations

Mar 15, 2016·Frontiers in Psychology·Giulia AvvenutiAnna Giardini
Aug 11, 2020·Current Atherosclerosis Reports·Kevin S MastersKaitlyn M Vagnini
Sep 21, 2021·International Journal of Clinical Practice·Saul LovattChun Shing Kwok

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.